Description
BSE notice regarding the listing of new securities of ZIM Laboratories Limited on the equity segment.
Summary
BSE has issued a notice (No. 20260410-22) dated April 10, 2026, announcing the listing of new securities of ZIM Laboratories Limited on the equity segment. This is a standard listing operations notice issued by the Listing Operations department.
Key Points
- Notice Number: 20260410-22
- ZIM Laboratories Limited’s new securities are being listed on BSE’s equity segment
- Issued by the Listing Operations department under the company-related category
- No attachments are included with this notice
Regulatory Changes
No specific regulatory changes are indicated in this notice. This is a standard listing notification.
Compliance Requirements
No additional compliance requirements are specified in this notice beyond the standard listing obligations applicable to newly listed securities.
Important Dates
- Notice Date: April 10, 2026
- Listing effective as per the notice issued on April 10, 2026
Impact Assessment
This notice has a limited market impact as it pertains to the routine listing of new securities for ZIM Laboratories Limited. Investors and traders interested in ZIM Laboratories should note the availability of these new securities on the BSE equity segment. No broader market or systemic implications are expected.
Impact Justification
Routine listing of new securities for a single company with no attachments or additional regulatory requirements indicated.